Quadmedicine: 투자판단관련주요경영사항(임상시험계획승인신청)
AI reading
★★★ Neutral · Material event
알레르기 반응 응급치료제 임상 1상 계획 승인 신청
An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).
For information only. Not investment advice.